MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$872K
Free Cash flow
-$12,479K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from related parties in...
Sales of investments
Maturity of investments
Others
Negative Cash Flow Breakdown
Net loss
Purchases of investments
Inventory
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-12,923
-14,275
-12,497
-11,505
Depreciation and amortization expense
674
706
790
804
Loss on fixed asset impairment
-
-
-
0
Noncash interest expense
-
-
73
24
Amortization of debt discount and issuance costs
85
86
-
-
Stock-based compensation expense
1,321
1,223
627
1,146
Provision for excess and obsolete inventory
10
0
695
7
Noncash lease expense
-
-
1,218
-
Non-cash lease expense
304
-609
-
305
Gain on revaluation of warrant liability
-48
-70
-172
41
Accretion on investments
-56
-131
-57
-145
Other
-57
-58
-61
44
Accounts receivable
-852
3,233
-2,298
-618
Inventory
1,832
-144
-3,098
514
Prepaid expenses and other current assets
-400
318
-61
-77
Other long-term assets
-16
13
-74
10
Accounts payable
408
530
549
251
Accrued expenses and other current liabilities
-955
-2,232
1,097
599
Other long-term liabilities
-
-
48
16
Deferred revenue
-1,127
1,900
-336
-1,065
Net cash used in operating activities
-12,702
-15,058
-3,246
-9,051
Purchases of property and equipment
-223
394
92
73
Purchases of investments
2,004
3,016
4,021
20,765
Sales of investments
3,002
2,006
0
2,505
Maturity of investments
3,000
10,000
8,000
8,750
Net cash provided by investing activities
4,221
8,596
3,887
-9,583
Proceeds from issuance of class a common stock - stock option exercise
67
116
6
62
Proceeds from issuance of class a common stock - employee stock purchase plan
0
140
0
72
Proceeds from issuance of debt
-
-
0
20,000
Payments of debt issuance costs
-
-
0
878
Issuance of class a common stock under the atm offering
-
-
445
-
Tax withholding on settlement of restricted stock units
0
-
0
1
Proceeds from related parties in underwritten and d&o offerings, net of underwriting discounts
9,395
-
-
-
Payments of third-party offering costs
100
-
-
-
Payments on finance lease obligations
9
9
8
8
Net cash provided by financing activities
9,353
247
443
19,247
Net (decrease) increase in cash, cash equivalents and restricted cash
872
-6,215
1,084
613
Cash, cash equivalents and restricted cash at beginning of period
14,099
20,314
19,230
17,276
Cash, cash equivalents and restricted cash at end of period
14,971
14,099
20,314
19,230
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from related
parties in underwritten...
$9,395K
Sales of investments
$3,002K
Maturity of investments
$3,000K
(-86.96%↓ Y/Y)
Proceeds from issuance of
class a common stock -...
$67K
(-84.16%↓ Y/Y)
Purchases of property and
equipment
-$223K
(-132.55%↓ Y/Y)
Net cash provided by
financing activities
$9,353K
(11446.91%↑ Y/Y)
Net cash provided by
investing activities
$4,221K
(-78.92%↓ Y/Y)
Canceled cashflow
$109K
Canceled cashflow
$2,004K
Net (decrease)
increase in cash, cash...
$872K
(-34.97%↓ Y/Y)
Canceled cashflow
$12,702K
Payments of third-party
offering costs
$100K
Payments on finance lease
obligations
$9K
(-35.71%↓ Y/Y)
Stock-based compensation
expense
$1,321K
(-41.55%↓ Y/Y)
Accounts receivable
-$852K
(42.08%↑ Y/Y)
Depreciation and
amortization expense
$674K
(-59.35%↓ Y/Y)
Accounts payable
$408K
(-49.00%↓ Y/Y)
Prepaid expenses and
other current assets
-$400K
(-119.78%↓ Y/Y)
Non-cash lease expense
$304K
(-50.08%↓ Y/Y)
Amortization of debt discount
and issuance costs
$85K
Other
-$57K
(-235.29%↓ Y/Y)
Accretion on investments
-$56K
(62.42%↑ Y/Y)
Other long-term
assets
-$16K
Provision for excess and
obsolete inventory
$10K
(-97.73%↓ Y/Y)
Purchases of investments
$2,004K
(-12.49%↓ Y/Y)
Net cash used in
operating activities
-$12,702K
(32.31%↑ Y/Y)
Canceled cashflow
$4,183K
Net loss
-$12,923K
(44.11%↑ Y/Y)
Inventory
$1,832K
(63.72%↑ Y/Y)
Deferred revenue
-$1,127K
(-143.41%↓ Y/Y)
Accrued expenses and
other current...
-$955K
(42.75%↑ Y/Y)
Gain on revaluation
of warrant...
-$48K
Buy us a coffee
RAPID MICRO BIOSYSTEMS, INC. (RPID)
RAPID MICRO BIOSYSTEMS, INC. (RPID)